Enhanced Arsenite-Induced Hepatic Morphological and Biochemical Changes in Phenobarbital-Pretreated Rats

Toxicologic Pathology

Volumn 24, Issue 2, 1996, Pages 172-180

  Albores, Arnulfo ^a   Cebrián, Mariano E ^a   García Vargas, Gonzalo G ^a   Connelly, John C ^b   Price, Shirley C ^b   Hinton, Richard H ^b   Bach, Peter H ^c   Bridges, James W ^b  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b UNIVERSITY OF SURREY   (United Kingdom)

^c UNIVERSITY OF EAST LONDON   (United Kingdom)

Author keywords

Cytochrome P 450; heme metabolism; histopathology; liver; mixed function oxidase

Indexed keywords

ADENOSINE TRIPHOSPHATE; ARSENITE SODIUM; BENZPHETAMINE; CYTOCHROME P450; ETHOXYRESORUFIN; GLYCOGEN; MYELIN; PENTOXYRESORUFIN; PHENOBARBITAL; PORPHOBILINOGEN SYNTHASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEGENERATION; CELL VACUOLE; CONTROLLED STUDY; DEALKYLATION; ELECTRON MICROSCOPY; INTRAHEPATIC BILE DUCT; LIVER NECROSIS; LIVER TOXICITY; MALE; NONHUMAN; PHAGOSOME; PRIORITY JOURNAL; RAT;

ANIMALS; ARSENITES; CYTOCHROME P-450 ENZYME SYSTEM; DRUG SYNERGISM; ENZYME INDUCTION; HEME; HEPATITIS, TOXIC; LIVER; LIVER GLYCOGEN; MALE; MICROSCOPY, ELECTRON; MICROSOMES, LIVER; MIXED FUNCTION OXYGENASES; PHENOBARBITAL; RATS; RATS, WISTAR;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0029922932     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1177/019262339602400205     Document Type: Article

References (36)

1. Agency for Toxic Substances and Disease Registry (ATSDR) (1993). Toxicological Profile for Arsenic. U.S. Department of Health and Human Services, Public Health Service, ATSDR, Atlanta, Georgia.
2. Albores A., Cebrián ME, Bach PH, Connelly JC, and Bridges JW (1992). Effects of arsenite on hepatic mixed-function oxidase activity in rats. Xenobiotica 22: 591-597.
3. Albores A., Cebrián ME, Bach PH, Connelly JC, Hinton RH, and Bridges JW (1989). Sodium arsenite induced alterations in bilirubin excretion and heme metabolism. J. Biochem. Toxicol. 4: 73-78.
4. Beauchamp RO, Bus JS, Popp JA, Boreiko CJ, and Goldberg L. (1983). A critical review of the literature on carbon disulfide toxicity. C.R.C. Crit. Rev. Toxicol. 11: 169-277.
5. Berger PC and Herdson PB (1966). Phenobarbital-induced fine structural changes in rat liver. Am. J. Pathol. 48: 793-809.
6. Burke MD and Mayer RT (1983). Differential effects of phenobarbital and 3-methylcholanthrene induction on the hepatic microsomal metabolism and cytochrome P-450 binding phenoxazone and homologous series of its n-alkylethers (alkoxyresorufins). Chem.-Biol. Interact. 45: 243-258.
7. Cebrián ME, Albores A., Connelly JC, and Bridges JW (1988). Assessment of arsenic effects on cytosolic heme status using tryptophan pyrrolase as an index. J. Biochem. Toxicol. 3: 77-86.
8. Chen C-J. and Lin L-J. (1994). Human carcinogenicity and atherogenicity induced by chronic exposure to inorganic arsenic. In: Arsenic in the Environment, Part II: Human Health and Ecosystem Effects, JO Nriagu (ed). John Wiley and Sons, New York, pp. 109-131.
9. Crane AK and Lipman T. (1953). The effect of arsenate on aerobic phosphorylation. J. Biol. Chem. 201: 25-33.
10. Culling CPA (1974). Handbook of Histopathology and Histochemical Techniques, 3rd ed. Butterworths, London.
11. De Matteis F. (1977). Hepatotoxicity of carbon disulfide and other chemicals: Possible significance of their metabolism by oxidative desulfuration. In: Biological and Reactive Metabolites: Formation, Toxicity and Activation, DJ Jollow, JJ Kocsis, RR Snyder, and H Vainio (eds). Plenum Press, New York, pp. 314-319.
12. De Matteis F. and Gibbs AH (1972). Stimulation of liver 5-aminolevulinate synthetase by drugs and its relevance on drug induced accumulation of cytochrome P-450. Biochem. J. 126: 1149-1160.
13. Dehlinger PJ and Schimke RT (1972). Effects of phenobarbital 3-methylcholanthrene and hematin on the synthesis of protein components of rat liver microsomal membranes. J. Biol. Chem. 247: 1257-1264.
14. Delnomdedieu M., Basti MM, Otvos JDM, and Thomas DJ (1993). Transfer of arsenite from glutathione to dithiols: A model for interaction. Chem. Res. Toxicol. 6: 598-602.
15. Díaz-Barriga F., Llamas E., Mejia JJ, Carrizales L., Santoyo ME, Vega-Vega L., and Yanez L. (1990). Arsenic-cadmium interactions in rats. Toxicology 64: 191-203.
16. Gamucio JJ and Miller DL (1981). Functional implications of liver cell heterogeneity. Gastroenterology 80: 393-403.
17. Gresser MJ (1981). ADP arsenate formation by submitochondrial particles under phosphorylating conditions. J. Biol. Chem. 256: 5981-5983.
18. Gyurasics A., Varga F., and Gregus Z. (1991). Glutathione-dependent biliary excretion of arsenic. Biochem. Pharmacol. 4: 465-468.
19. Ibrahim NG, Gruenspetch NR, and Freedman ML (1978). Hemin feedback inhibition at reticulocyte δ-aminolevulinic acid dehydratase. Biochem. Biophys. Res. Commun. 80: 722-728.
20. Keyse SM and Tyrrel RM (1989). Heme oxygenase, is the major 32-kDa stress protein induced in human skin fibroblasts by UV-A radiation, hydrogen peroxide and sodium arsenite. Proc. Natl. Acad. Sci. USA 86: 99-103.
21. Kreppel H., Liu J., Liu Y., Reichl FX, and Klaassen CD (1994). Zinc-induced arsenite tolerance in mice. Fund. Appl. Toxicol. 23: 32-37.
22. Lu AYH, Stroebel HW, and Coon MJ (1970). Properties of a solubilized form of the cytochrome P-450 containing mixed-function oxidase of liver microsomes. Mol. Pharmacol. 6: 213-220.
23. Mann AH, Price SC, Mitchell FE, Grasso P., Hinton RH, and Bridges JW (1985). Comparison of the short term effect of di(2-ethylhexyl)phthalate di(n-hexyl)- and di(n-octyl)phthalate in rats. Toxicol. Appl. Pharmacol. 4: 116-132.
24. McLean AEM, McLean E., and Judah JD (1965). Cellular necrosis in the liver induced and modified by drugs. Int. Bull. Exp. Pathol. 4: 127-157.
25. Nakagawa K. (1992). Modification by phenobarbital of decreased glutathione contents and glutathione S-transferase activity in livers of lead-treated mice. Toxicol. Lett. 62: 63-71.
26. Nebert DW and Gonzalez FJ (1987). P450 genes: Structure evolution and regulation. Ann. Rev. Biochem. 56: 945-993.
27. Omura T. and Sato R. (1964). The carbon monooxide-binding pigment of liver microsomes. J. Biol. Chem. 239: 2370-2378.
28. Remmer H. and Merker HJ (1963). Drug induced changes in the liver endoplasmic reticulum: Association with drug-metabolizing enzymes. Science 142: 1657-1658.
29. Scott N., Hatlelid KM, Mackenzie NE, and Carter DE (1993). Reaction of arsenic(III) and arsenic(V) species with glutathione. Chem. Res. Toxicol. 6: 102-106.
30. Staubli W., Hess R., and Weibel ER (1969). Correlated morphometric and biochemical studies on the liver cell. II. Effects of phenobarbital on rat hepatocytes. J. Cell. Biol. 42: 92-113.
31. Stroebel HW and Digman JD (1978). Purification and properties of NADPH-cytochrome P-450 reductase. Methods Enzymol. 52: 89-96.
32. Tenhunen R., Marver HS, and Schmid R. (1969). Microsomal heme oxygenase. Characterization of the enzyme. J. Biol. Chem. 244: 6388-6394.
33. Tephly TR, Hasegawa E., and Baron J. (1971). Effects of drugs on heme synthesis in the liver. Metabolism 20: 200-214.
34. Terada T., Ishida F., and Nakamuna Y. (1989). Vascular plexus around intrahepatic bile ducts in normal livers and periportal hypertension. J. Hepatol. 8: 139-149.
35. U.S. Environmental Protection Agency (EPA) (1993). A Guidebook to Comparing Risks and Setting Environmental Priorities, Ch. 2. EPA, Washington, D.C.
36. Wolff N. (1988). Cell, Tissues and Disease. The Basis of Pathology, 2nd ed. Ballière Tyndall, Cambridge, UK.